Sun Pharma Advanced Research Co. Ltd. NSE:SPARC

Press Release Dec 03 2021

Published December 3, 2021 at 7:06 p.m. UTC

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated December 03, 2021, titled "SPARC enters into a licensing agreement with Biomodifying to acquire exclusive rights for antibody against unique oncology target.".

View Attachment